Kura Oncology, Inc.KURANASDAQ
Loading
| Metric | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | -67.83% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | -68.68% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +12.67% | +4.18% | +1.10% | +0.80% | +1.05% |
| Weighted Average Shares Diluted Growth | +12.67% | +4.18% | +1.10% | +0.80% | +1.05% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -56.43% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | -57.23% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +69.32% | +34.28% | +32.48% | +35.62% | -2.87% |
| Book Value per Share Growth | -7.59% | -30.75% | -35.17% | -43.22% | -58.34% |
| Debt Growth | -3.52% | +14.05% | +16.37% | +17.06% | +23.28% |
| R&D Expense Growth | +60.66% | +54.33% | +58.04% | +62.83% | +23.23% |
| SG&A Expenses Growth | +71.75% | +27.21% | +52.77% | +80.64% | +62.60% |